Attached files

file filename
S-1/A - EASTGATE BIOTECH CORPforms1amend1draftedgar.htm
EX-10 - EASTGATE BIOTECH CORPexh104promissorynotedemand.htm
EX-4 - EASTGATE BIOTECH CORPexhibit41specimenstockcertif.htm
EX-10 - EASTGATE BIOTECH CORPexh103kodiakregistrationrigh.htm
EX-10 - EASTGATE BIOTECH CORPexh102kodiakinvestmentagreem.htm
EX-3 - EASTGATE BIOTECH CORPexh32amendmentstocertificate.htm
EX-5 - EASTGATE BIOTECH CORPexh51legalopinionandconsentf.htm
EX-21 - EASTGATE BIOTECH CORPexhibit211subsidiaries.htm
EX-10 - EASTGATE BIOTECH CORPexh106distributionagreementw.htm
EX-10 - EASTGATE BIOTECH CORPexh105securitiespurchaseagrn.htm







Registered with the Public Company

Accounting Oversight Board





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




To the Board of Directors

Eastgate Acquisitions Corp.


As independent registered public accountants, we hereby consent to the use of our report dated April 10, 2012, with respect to the financial statements of Eastgate Acquisitions Corp., in its registration statement on Amendment No. 1 to Form S-1 relating to the registration of 15,472,450 shares of common stock.  We also consent to the reference of our firm under the caption “interests of name experts and counsel” in the registration statement.




/s/ SADLER, GIBB AND ASSOCIATES, LLC


Salt Lake City, UT

January 29, 2013